Loading page...

Back
RFA-FD-26-004 Open
Send to:
Food and Drug Administration United States

Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers

Open

Overview

Funding agency
Food and Drug Administration HHS-FDA
Reference
RFA-FD-26-004
Region
United States
Source
Grants.gov (US Federal)

Description

Background The FDA Oncology Center of Excellence (OCE) aims to advance the development and regulation of oncology products for patients with cancer. The Pediatric Oncology Program and Rare Cancers Program were established to facilitate and expedite drug development for pediatric and other rare cancers. OCE’s Project Catalyst connects scientific knowledge, creative insight, and medical…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed Food and Drug Administration Retail Food Safety Regulatory Association Collaboration Food and Drug Administration Pathways for Regulatory Innovation and Strategic Modernization (PRISM) Food and Drug Administration

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top